WJ01024
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for WJ01024, covering 2025-06-26 to 2026-03-30. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Safety , Efficacy and Pharmacokinetics of WJ01024 Tablets Combined With Ruxolitinib in Patients With Myelofibrosis [Phase 1, Phase 2]